Real-World Treatment Patterns of Novel Drugs in Relapsed or Refractory Acute Lymphoblastic Leukemia Patients in Japan - supplementary material

  

Figure S1. Distribution of the number of white blood cell tests.

The tests were performed within one month prior to the index date, from one to six months after the index date, and more than six months after the index date.

Figure S2. Distribution of the number of hemoglobin tests.

The tests were performed within one month prior to the index date, from one to six months after the index date, and more than six months after the index date.

Figure S3. Distribution of the number of platelet tests.

The tests were performed within one month prior to the index date, from one to six months after the index date, and more than six months after the index date.

Figure S4. Distribution of the number of aspartate aminotransferase tests.

The tests were performed within one month prior to the index date, from one to six months after the index date, and more than six months after the index date.

Figure S5. Distribution of the number of alanine aminotransferase tests.

The tests were performed within one month prior to the index date, from one to six months after the index date, and more than six months after the index date.

Figure S6. Distribution of the number of neutrophil tests/

The tests were performed within one month prior to the index date, from one to six months after the index date, and more than six months after the index date.

Figure S7. Distribution of the number of lymphocyte tests.

The tests were performed within one month prior to the index date, from one to six months after the index date, and more than six months after the index date.

Figure S8. Distribution of the number of alkaline phosphatase tests.

The tests were performed within one month prior to the index date, from one to six months after the index date, and more than six months after the index date.

Figure S9. Distribution of the number of gamma-glutamyl transpeptidase tests.

The tests were performed within one month prior to the index date, from one to six months after the index date, and more than six months after the index date.

Figure S10. Distribution of the number of bilirubin tests.

The tests were performed within one month prior to the index date, from one to six months after the index date, and more than six months after the index date.

Figure S11. Distribution of the number of creatinine tests.

The tests were performed within one month prior to the index date, from one to six months after the index date, and more than six months after the index date

  

Table S1. Disease codes

  

Table S2. Drug codes

  

Table S3. Laboratory test codes